Literature DB >> 8304244

Alterations in interleukin-6 production by LPS- and Con A-stimulated mixed splenocytes, spleen macrophages and lymphocytes in prenatally diazepam-exposed rats.

A A Schreiber1, K Frei, W Lichtensteiger, M Schlumpf.   

Abstract

Prenatal exposure to diazepam leads to a suppression of mitogen or allogen-induced lymphocyte proliferation as well as to a reduced production of tumour necrosis factor (TNF)-alpha from rat splenocytes during postnatal development of rats. We analysed the secretion of interleukin (IL)-6 which occurs at a later stage of the cytokine cascade. Splenocytes of male offspring from Long Evans rats, treated with a daily dose of diazepam (1.25 mg/kg) from gestational day 14 to 20, were stimulated with lipopolysaccharide (LPS) and concanavalin A (Con A). In response to LPS, IL-6 liberation was significantly lower in mixed splenocytes and spleen macrophages of 2 and 8 week old prenatally diazepam-treated rats than in controls. Spleen lymphocyte preparations of prenatally treated animals exhibited a reduction of IL-6 release at 12 h and an increase at 24 h of incubation. At 2 weeks of age, Con A-induced IL-6 production could only be detected in mixed splenocytes; prenatally treated rats were releasing significantly less IL-6 than controls. In 8 week old rats, IL-6 liberation from mixed splenocytes and spleen macrophages was significantly lower in prenatally treated animals than in controls. Spleen lymphocytes presented a complex response picture depending upon incubation conditions. Our data indicate that in prenatally diazepam-exposed rats, the disturbance of cytokine release also extends to cytokines which play an important role in the later phases of immune responses.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8304244     DOI: 10.1007/BF01998970

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  24 in total

1.  Interleukin-6 production by tumor necrosis factor and lipopolysaccharide-stimulated rat renal cells.

Authors:  E Pirotzky; R M Delattre; A Hellegouarch; M O Lonchampt; L Aarden; P Braquet; P Galanaud
Journal:  Clin Immunol Immunopathol       Date:  1990-08

2.  Multiple actions of interleukin 6 within a cytokine network.

Authors:  G G Wong; S C Clark
Journal:  Immunol Today       Date:  1988-05

Review 3.  The biology of interleukin-6.

Authors:  T Kishimoto
Journal:  Blood       Date:  1989-07       Impact factor: 22.113

4.  [In vitro studies of the effect of flunitrazepam on cellular immune parameters].

Authors:  J Nadstawek; P Mallmann; P M Lauven; A Koenig
Journal:  Anasth Intensivther Notfallmed       Date:  1989-10

5.  IFN-gamma is an essential cosignal for triggering IFN-beta 2/BSF-2/IL-6 gene expression in human monocytic cell lines.

Authors:  J Sanceau; F Beranger; C Gaudelet; J Wietzerbin
Journal:  Ann N Y Acad Sci       Date:  1989       Impact factor: 5.691

6.  Prenatal diazepam induced persisting depression of cellular immune responses.

Authors:  M Schlumpf; H Ramseier; W Lichtensteiger
Journal:  Life Sci       Date:  1989       Impact factor: 5.037

7.  Interleukin 1 and poly(rI).poly(rC) induce production of a hybridoma growth factor by human fibroblasts.

Authors:  J Van Damme; S Cayphas; G Opdenakker; A Billiau; J Van Snick
Journal:  Eur J Immunol       Date:  1987-01       Impact factor: 5.532

8.  [Interleukins and inflammation].

Authors:  J M Cavaillon
Journal:  Pathol Biol (Paris)       Date:  1990-01

Review 9.  The cytokine network.

Authors:  F R Balkwill; F Burke
Journal:  Immunol Today       Date:  1989-09

10.  Prenatal benzodiazepine immunosuppression: possible involvement of peripheral benzodiazepine site.

Authors:  M Schlumpf; R Parmar; H R Ramseier; W Lichtensteiger
Journal:  Dev Pharmacol Ther       Date:  1990
View more
  1 in total

1.  Mice with heterozygous deficiency of lipoic acid synthase have an increased sensitivity to lipopolysaccharide-induced tissue injury.

Authors:  Xianwen Yi; Kuikwon Kim; Weiping Yuan; Longquan Xu; Hyung-Suk Kim; Jonathon W Homeister; Nigel S Key; Nobuyo Maeda
Journal:  J Leukoc Biol       Date:  2008-10-09       Impact factor: 4.962

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.